Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -35.91 |
| peg ratio | -0.36 |
| price to book ratio | 5.94 |
| price to sales ratio | 147,323.76 |
| enterprise value multiple | -30.24 |
| price fair value | 5.94 |
profitability ratios | |
|---|---|
| gross profit margin | -174.67% |
| operating profit margin | -549901.66% |
| pretax profit margin | -417725.82% |
| net profit margin | -409200.94% |
| return on assets | -15.59% |
| return on equity | -15.78% |
| return on capital employed | -21.79% |
liquidity ratio | |
|---|---|
| current ratio | 25.51 |
| quick ratio | 25.51 |
| cash ratio | 18.71 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 44,511.99 |
| days of payables outstanding | 702.32 |
| cash conversion cycle | 43,809.67 |
| receivables turnover | 0.01 |
| payables turnover | 0.52 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | 0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.01 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -21.82 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.29 |
| cash per share | 7.85 |
| operating cash flow per share | -1.28 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -21.82 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -128.00 |
Frequently Asked Questions
MoonLake Immunotherapeutics (MLTX) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. MoonLake Immunotherapeutics (NASDAQ:MLTX)'s trailing twelve months ROE is -15.78%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. MoonLake Immunotherapeutics (MLTX) currently has a ROA of -15.59%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
MLTX reported a profit margin of -409200.94% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 25.51 in the most recent quarter. The quick ratio stood at 25.51, with a Debt/Eq ratio of 0.01.